130 related articles for article (PubMed ID: 18623192)
1. In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations.
Shukla C; Friden P; Juluru R; Stagni G
J Pharm Sci; 2009 Mar; 98(3):917-25. PubMed ID: 18623192
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of acyclovir in rabbit skin after i.v.-bolus, ointment, and iontophoretic administrations.
Stagni G; Ali ME; Weng D
Int J Pharm; 2004 Apr; 274(1-2):201-11. PubMed ID: 15072796
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.
Siddoju S; Sachdeva V; Friden PM; Banga AK
Ther Deliv; 2012 Mar; 3(3):327-38. PubMed ID: 22833993
[TBL] [Abstract][Full Text] [Related]
4. The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin.
Padula C; Sartori F; Marra F; Santi P
Pharm Res; 2005 Sep; 22(9):1519-24. PubMed ID: 16132364
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y; Zahui T; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir skin depot characterization following in vivo iontophoretic delivery.
Siddoju S; Sachdeva V; Friden PM; Yu YY; Banga AK
Skin Res Technol; 2011 May; 17(2):234-44. PubMed ID: 21272079
[TBL] [Abstract][Full Text] [Related]
7. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
[TBL] [Abstract][Full Text] [Related]
8. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.
Abla N; Naik A; Guy RH; Kalia YN
Pharm Res; 2006 Aug; 23(8):1842-9. PubMed ID: 16850271
[TBL] [Abstract][Full Text] [Related]
9. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis.
Volpato NM; Nicoli S; Laureri C; Colombo P; Santi P
J Control Release; 1998 Jan; 50(1-3):291-6. PubMed ID: 9685896
[TBL] [Abstract][Full Text] [Related]
10. Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; De Clercq E; El-Shattawy HH
J Pharm Sci; 1998 Aug; 87(8):917-21. PubMed ID: 9687333
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis.
Volpato NM; Santi P; Colombo P
Pharm Res; 1995 Nov; 12(11):1623-7. PubMed ID: 8592660
[TBL] [Abstract][Full Text] [Related]
12. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of amitriptyline in rabbit skin and plasma following iontophoretic administrations.
Patel S; Shukla C; Patel G; Stagni G
Drug Dev Ind Pharm; 2010 Apr; 36(4):379-84. PubMed ID: 19754244
[TBL] [Abstract][Full Text] [Related]
14. Iontophoretic delivery of acyclovir: intradermal drug monitoring using microdialysis and quantification by skin extraction.
Siddoju S; Sachdeva V; Friden PM; Banga AK
PDA J Pharm Sci Technol; 2011; 65(5):432-44. PubMed ID: 22293833
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro.
Liu H; Pan WS; Tang R; Luo SD
Pharmazie; 2004 Mar; 59(3):203-6. PubMed ID: 15074594
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
17. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
18. Are all aciclovir cream formulations bioequivalent?
Trottet L; Owen H; Holme P; Heylings J; Collin IP; Breen AP; Siyad MN; Nandra RS; Davis AF
Int J Pharm; 2005 Nov; 304(1-2):63-71. PubMed ID: 16139970
[TBL] [Abstract][Full Text] [Related]
19. Quantification of uptake and clearance of acyclovir in skin layers.
Nair AB
Antivir Ther; 2016; 21(1):17-25. PubMed ID: 26046929
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid.
Klimowicz A; Farfał S; Bielecka-Grzela S
J Clin Pharm Ther; 2007 Apr; 32(2):143-8. PubMed ID: 17381664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
